Claudia Comacchio is presenting a poster about Philochem’s ACP3 antibody therapeutics on April 29, entitled “Generation and in vivo characterization of a novel antibody targeting Prostatic Acid Phosphatase (ACP-3)” [Abstract Number 4781].

Gudrun Thorhallsdottir is presenting a poster about Philochem’s bispecific antibodies on April 29, entitled “L19-mTNF as a novel synergistic combination partner to enhance the efficacy of CD3-based bispecific antibodies in colorectal cancer” [Abstract Number 6017].